Kalydeco 150 MG tablet 56S
Ended Awarded Last action
- Contract number
- SPE2DR26FHKU2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,249
Award facts
- Contract value 100% obligated
- $27,249.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27,249.26 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 56 tablets of Kalydeco 150 mg. This firm fixed-price delivery order, issued on January 2, 2026, with an ultimate completion date of January 5, 2026, carries no set-aside designation, indicating the contractor competed in unrestricted federal procurement. The award was issued without involvement of subcontractors and represents a routine pharmaceutical supply transaction to support Department of Defense medical operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, awarded in November 2025 with a $499.999 billion ceiling value extending through December 31, 2036. The PPV-G GEN V represents part of the broader $30.3 billion acquisition strategy designed to ensure consistent pharmaceutical supply across global military healthcare facilities. DMS Pharmaceutical Group's established performance on numerous prior delivery orders, spanning diverse product categories from specialty oncology treatments to routine pharmaceuticals, demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FHKU2?
SPE2DR26FHKU2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26FHKU2 worth?
The government has obligated $27,249 on SPE2DR26FHKU2.
Is contract SPE2DR26FHKU2 an order under another contract?
Yes. SPE2DR26FHKU2 is a delivery order under SPE2DR25D9222, an indefinite delivery contract.
Was contract SPE2DR26FHKU2 competed?
The extent of competition for SPE2DR26FHKU2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award